Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies
Danielle Shafer, Amanda B. Kagan, Michelle A. Rudek, Maciej Kmieciak, Mary Beth Tombes, Ellen Shrader, Dipankar Bandyopadhyay, Daniel Hudson, Heidi Sankala, Caryn Weir, Jeffrey E. Lancet, Steven Grant
Topics & Concepts
MedicineDysgeusiaNauseaAdverse effectPharmacologyInternal medicineMucositisToxicityRefractory (planetary science)Myeloid leukemiaNeutropeniaPharmacokineticsGastroenterologyOncologyPopulationEnvironmental healthAstrobiologyPhysicsHistone Deacetylase Inhibitors ResearchAcute Myeloid Leukemia ResearchBiochemical and Molecular Research